When Singapore began building its research ecosystem some 25 years ago, it started “from a very low base”, says Prof Tan Sze Wee, assistant chief executive of biomedical research at the Agency for Science, Technology and Research (A*Star).
In June, Singapore’s Biopolis marked two decades since its completion as a “key project” by government industrial developer JTC.
Designed as a research and development (R&D) hub for the biomedical industry, the precinct has grown to include 13 buildings, occupying a total floor area of 3.7 million sq ft in its sixth phase of development.
